Neurological disorders impose a substantial global health burden, compounded by the limited regenerative capacity of neural tissues and the absence of curative therapies. 3D bioprinting offers a transformative tool to model, replace, and regenerate neural tissues through the precise spatial organization of cells and biomaterials. In this perspective article, recent advances are examined in: i) the development of in vitro neural platforms for disease modeling and drug screening; ii) bioprinted acellular scaffolds designed to guide endogenous neural repair; and iii) cell-laden constructs that aim to replace or reconstruct damaged neural circuits. Key translational challenges are critically evaluated, including vascularization, immune integration, functional maturation, and replicating the complex cytoarchitectures of native neural tissues. Highlighting representative preclinical studies and emerging biofabrication technologies, we discuss how innovations in biomaterials, scaffold design, stem cell biology, and neuroengineering are converging to overcome existing limitations. Through tailored strategies and interdisciplinary collaboration, 3D bioprinting is poised to redefine therapeutic paradigms and drive the development of next-generation, personalized regenerative therapies for neurological diseases and injuries.